Nanexa AB (publ) (STO:NANEXA)
3.580
+0.030 (0.85%)
Jul 6, 2026, 1:26 PM CET
Nanexa AB Market Cap
Nanexa AB has a market cap or net worth of 655.99 million as of July 6, 2026. Its market cap has increased by 53.99% in one year.
Market Cap
655.99M
Enterprise Value
583.96M
Revenue
54.41M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.58
Market Cap Chart
Since June 17, 2015, Nanexa AB's market cap has increased from 49.07M to 655.99M, an increase of 1,236.76%. That is a compound annual growth rate of 26.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 6, 2026 | 655.99M | -7.10% |
| Dec 30, 2025 | 706.11M | 140.91% |
| Dec 30, 2024 | 293.10M | 292.61% |
| Dec 29, 2023 | 74.66M | -46.84% |
| Dec 30, 2022 | 140.43M | -30.75% |
| Dec 30, 2021 | 202.78M | -19.37% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioGaia AB | 12.34B |
| Cereno Scientific AB | 1.60B |
| Orexo AB | 848.60M |
| Dicot Pharma AB | 707.61M |
| EQL Pharma AB | 683.61M |
| Enzymatica AB | 568.00M |
| Cinclus Pharma Holding AB | 520.29M |
| Moberg Pharma AB | 444.16M |